Illumina (ILMN) Financials

$82.49 +2.12 (+2.64%)

Closing price 05/27/2025 04:00 PM Eastern

Extended Trading

$82.76 +0.28 (+0.33%)

As of 04:18 AM Eastern

Annual Income Statements for Illumina

This table shows Illumina's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/29/2024	12/31/2023	1/1/2023	1/2/2022	1/3/2021	12/29/2019	12/30/2018	12/31/2017	1/1/2017	1/3/2016
Net Income / (Loss) Attributable to Common Shareholders	-1,223	-1,161	-4,404	762	656	1,002	826	726	463	462
Consolidated Net Income / (Loss)	-1,223	-1,161	-4,404	762	656	990	782	678	428	458
Net Income / (Loss) Continuing Operations	-1,223	-1,161	-4,404	762	656	990	782	678	428	458
Total Pre-Tax Income	-1,179	-1,117	-4,336	884	856	1,118	894	1,043	561	583
Total Operating Income	-833	-1,069	-4,179	-123	580	985	883	606	587	613
Total Gross Profit	2,861	2,744	2,972	3,154	2,203	2,467	2,300	1,826	1,666	1,549
Total Revenue	4,372	4,504	4,584	4,526	3,239	3,543	3,333	2,752	2,398	2,220
Operating Revenue	4,372	4,504	4,584	4,526	3,239	3,543	3,333	2,752	2,398	2,220
Total Cost of Revenue	1,511	1,760	1,612	1,372	1,036	1,076	1,033	926	732	671
Operating Cost of Revenue	1,511	1,760	1,612	1,372	1,036	1,076	1,033	926	732	671
Total Operating Expenses	3,694	3,813	7,151	3,277	1,623	1,482	1,417	1,220	1,079	936
Selling, General & Admin Expense	1,092	1,612	1,297	2,092	941	835	794	674	584	516
Research & Development Expense	1,169	1,354	1,321	1,185	682	647	623	546	504	401
Impairment Charge	1,889	827	3,914	0.00	0.00	-	-	-	-	-
Other Special Charges / (Income)	-456	20	619	0.00	0.00	-	-	-	-9.00	19
Total Other Income / (Expense), net	-346	-48	-157	1,007	276	133	11	437	-26	-30
Interest Expense	100	77	26	61	49	52	57	37	33	43
Interest & Investment Income	46	58	11	0.00	41	75	44	19	10	21
Other Income / (Expense), net	-292	-29	-142	1,068	284	110	24	455	-3.00	-8.00
Income Tax Expense	44	44	68	122	200	128	112	365	133	125
Basic Earnings per Share	($7.69)	($7.34)	($28.00)	$5.07	$4.48	$6.81	$5.63	$4.96	$3.09	$3.19
Weighted Average Basic Shares Outstanding	159M	158M	157M	150M	147M	147M	147M	146M	147M	145M
Diluted Earnings per Share	($7.69)	($7.34)	($28.00)	$5.04	$4.45	$6.74	$5.56	$4.92	$3.07	$3.10
Weighted Average Diluted Shares Outstanding	159M	158M	157M	151M	148M	149M	149M	148M	148M	149M
Weighted Average Basic & Diluted Shares Outstanding	158.40M	158.90M	158M	157M	145.90M	147M	146.70M	146.40M	149.80M	144.70M

This table shows Illumina's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/30/2025	12/29/2024	9/29/2024	6/30/2024	3/31/2024	12/31/2023	10/1/2023	7/2/2023	4/2/2023	1/1/2023	10/2/2022
Net Income / (Loss) Attributable to Common Shareholders	131	186	705	-1,988	-126	-176	-754	-234	3.00	-139	-3,816
Consolidated Net Income / (Loss)	131	186	705	-1,988	-126	-176	-754	-234	3.00	-139	-3,816
Net Income / (Loss) Continuing Operations	131	186	705	-1,988	-126	-176	-754	-234	3.00	-139	-3,816
Total Pre-Tax Income	182	186	720	-1,976	-109	-168	-782	-89	-78	-167	-3,672
Total Operating Income	164	174	741	-1,637	-111	-163	-754	-88	-64	-127	-3,657
Total Gross Profit	683	728	745	721	667	673	684	732	655	673	717
Total Revenue	1,041	1,104	1,080	1,112	1,076	1,122	1,119	1,176	1,087	1,084	1,115
Operating Revenue	1,041	1,104	1,080	1,112	1,076	1,122	1,119	1,176	1,087	1,084	1,115
Total Cost of Revenue	358	376	335	391	409	449	435	444	432	411	398
Operating Cost of Revenue	358	376	335	391	409	449	435	444	432	411	398
Total Operating Expenses	519	554	4.00	2,358	778	836	1,438	820	719	800	4,374
Selling, General & Admin Expense	267	267	239	147	439	469	303	462	378	433	146
Research & Development Expense	252	252	253	325	339	340	315	358	341	346	325
Total Other Income / (Expense), net	18	12	-21	-339	2.00	-5.00	-28	-1.00	-14	-40	-15
Interest Expense	25	26	36	20	18	19	19	19	20	8.00	6.00
Interest & Investment Income	11	10	11	13	12	11	13	17	17	7.00	3.00
Other Income / (Expense), net	32	28	4.00	-332	8.00	3.00	-22	1.00	-11	-39	-12
Income Tax Expense	51	-	15	12	17	8.00	-28	145	-81	-28	144
Basic Earnings per Share	$0.83	$1.17	$4.43	($12.48)	($0.79)	($1.11)	($4.77)	($1.48)	$0.02	($0.89)	($24.26)
Weighted Average Basic Shares Outstanding	159M	159M	159M	159M	159M	158M	158M	158M	158M	157M	157M
Diluted Earnings per Share	$0.82	$1.17	$4.42	($12.48)	($0.79)	($1.11)	($4.77)	($1.48)	$0.02	($0.89)	($24.26)
Weighted Average Diluted Shares Outstanding	159M	159M	160M	159M	159M	158M	158M	158M	158M	157M	157M
Weighted Average Basic & Diluted Shares Outstanding	158.30M	158.40M	158.60M	159.30M	159.30M	158.90M	158.80M	158.30M	158.10M	158M	157.30M

This table details how cash moves in and out of Illumina's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/29/2024	12/31/2023	1/1/2023	1/2/2022	1/3/2021	12/29/2019	12/30/2018	12/31/2017	1/1/2017	1/3/2016
Net Change in Cash & Equivalents	79	-963	779	-578	-232	898	-77	490	-34	133
Net Cash From Operating Activities	837	478	392	545	1,080	1,051	1,142	875	779	786
Net Cash From Continuing Operating Activities	837	478	392	545	1,080	1,051	1,142	875	779	786
Net Income / (Loss) Continuing Operations	-1,223	-1,161	-4,404	762	656	990	782	678	428	458
Consolidated Net Income / (Loss)	-1,223	-1,161	-4,404	762	656	990	782	678	428	458
Depreciation Expense	224	235	215	176	156	151	140	110	90	73
Amortization Expense	130	197	179	107	71	83	80	76	81	93
Non-Cash Adjustments To Reconcile Net Income	2,616	1,354	4,426	-276	7.00	10	176	-265	131	121
Changes in Operating Assets and Liabilities, net	-910	-147	-24	-224	190	-183	-36	276	49	41
Net Cash From Investing Activities	-178	-231	-591	-1,069	-554	745	-1,813	-214	-515	-107
Net Cash From Continuing Investing Activities	-178	-231	-591	-1,069	-554	745	-1,813	-214	-515	-107
Purchase of Property, Plant & Equipment	-128	-195	-286	-208	-189	-209	-296	-310	-260	-143
Acquisitions	-81	-30	-265	-2,444	-98	-29	-100	-2.00	-29	-37
Purchase of Investments	-52	-6.00	-40	221	-2,058	-1,048	-2,859	-742	-895	-797
Divestitures	83	0.00	0.00	-	-	15	0.00	278	0.00	0.00
Net Cash From Financing Activities	-570	-1,210	1,000	-51	-766	-897	594	-176	-296	-545
Net Cash From Continuing Financing Activities	-570	-1,210	1,000	-51	-766	-897	594	-176	-296	-545
Repayment of Debt	-750	-1,236	0.00	-517	0.00	-550	-4.00	-9.00	-66	-245
Repurchase of Common Equity	-116	0.00	0.00	-	-736	-324	-201	-251	-249	-274
Payment of Dividends	-1.00	-1.00	0.00	-	-	-	-	-3.00	-29	-3.00
Issuance of Debt	1,241	0.00	991	988	0.00	0.00	735	5.00	5.00	0.00
Issuance of Common Equity	56	67	63	60	61	59	138	150	136	104
Other Financing Activities, net	-1,000	-40	-54	-582	-91	-82	-74	-68	-93	-127
Effect of Exchange Rate Changes	-10	0.00	-22	-3.00	8.00	-1.00	-	-	-2.00	-1.00
Cash Interest Paid	83	73	17	9.00	-	-	-	-	-	-
Cash Income Taxes Paid	105	65	122	233	119	164	99	149	60	17

This table details how cash moves in and out of Illumina's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/30/2025	12/29/2024	9/29/2024	6/30/2024	3/31/2024	12/31/2023	10/1/2023	7/2/2023	4/2/2023	1/1/2023	10/2/2022
Net Change in Cash & Equivalents	-14	258	-51	-188	60	121	-626	59	-517	1,011	-289
Net Cash From Operating Activities	240	364	316	80	77	224	139	105	10	147	-52
Net Cash From Continuing Operating Activities	240	364	316	80	77	224	139	105	10	147	-52
Net Income / (Loss) Continuing Operations	131	187	704	-1,988	-126	-175	-755	-234	3.00	-139	-3,816
Consolidated Net Income / (Loss)	131	187	704	-1,988	-126	-175	-755	-234	3.00	-139	-3,816
Depreciation Expense	52	54	54	57	59	60	59	59	57	57	56
Amortization Expense	17	17	16	48	49	49	49	49	50	49	47
Non-Cash Adjustments To Reconcile Net Income	39	66	113	2,308	129	145	973	128	108	152	4,008
Changes in Operating Assets and Liabilities, net	1.00	40	-571	-345	-34	145	-187	103	-208	28	-347
Net Cash From Investing Activities	-63	-48	-41	-41	-48	-85	-53	-37	-56	-102	-250
Net Cash From Continuing Investing Activities	-63	-48	-41	-41	-48	-85	-53	-37	-56	-102	-250
Purchase of Property, Plant & Equipment	-32	-29	-32	-31	-36	-51	-45	-47	-52	-88	-66
Acquisitions	-7.00	-	-81	-	0.00	-29	-	-	-1.00	-	-180
Purchase of Investments	-24	-19	-11	-10	-12	-5.00	10	-8.00	-3.00	-14	-4.00
Net Cash From Financing Activities	-195	-47	-332	-226	35	-27	-707	-3.00	-473	956	28
Net Cash From Continuing Financing Activities	-195	-47	-332	-226	35	-27	-707	-3.00	-473	956	28
Repurchase of Common Equity	-200	-17	-	-	-	-	-	-	-	-	-
Issuance of Common Equity	27	-	20	-	36	-	30	-	37	-	30
Other Financing Activities, net	-22	-30	-	-969	-1.00	-26	-2.00	-3.00	-9.00	-35	-2.00
Effect of Exchange Rate Changes	4.00	-11	6.00	-1.00	-4.00	9.00	-5.00	-	-	10	-15

This table presents Illumina's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/29/2024	12/31/2023	1/1/2023	1/2/2022	1/3/2021	12/29/2019	12/30/2018	12/31/2017	1/1/2017	1/3/2016
Total Assets	6,303	10,111	12,252	15,217	7,585	7,316	6,959	5,257	4,281	3,688
Total Current Assets	2,746	2,609	3,561	2,713	4,483	4,451	4,490	2,980	2,318	2,097
Cash & Equivalents	1,127	1,048	2,011	1,232	1,810	2,042	1,144	1,225	735	769
Short-Term Investments	93	6.00	26	107	1,662	1,372	2,368	920	824	617
Accounts Receivable	735	734	671	648	487	573	514	411	381	386
Inventories, net	547	587	568	431	372	359	386	333	300	271
Prepaid Expenses	244	234	285	295	152	105	78	91	78	54
Plant, Property, & Equipment, net	815	1,007	1,091	1,024	922	889	1,075	931	713	343
Total Noncurrent Assets	2,742	6,495	7,600	11,480	2,180	1,976	1,394	1,346	1,250	1,248
Goodwill	1,113	2,545	3,239	7,113	897	824	831	771	776	753
Intangible Assets	295	2,993	3,285	3,250	142	145	185	175	243	274
Noncurrent Deferred & Refundable Income Taxes	567	56	-	-	-	64	70	88	123	135
Other Noncurrent Operating Assets	767	901	1,076	1,117	1,141	943	308	312	108	87
Total Liabilities & Shareholders' Equity	6,303	10,111	12,252	15,217	7,585	7,316	6,959	5,257	4,281	3,688
Total Liabilities	3,930	4,366	5,653	4,477	2,891	2,703	3,053	2,288	1,967	1,807
Total Current Liabilities	1,547	1,570	2,773	1,093	1,244	665	1,804	746	705	610
Short-Term Debt	499	0.00	1,248	0.00	511	0.00	1,107	10	2.00	75
Accounts Payable	221	245	293	332	192	149	184	160	138	139
Accrued Expenses	827	1,325	1,232	761	541	516	513	432	342	387
Total Noncurrent Liabilities	2,383	2,796	2,880	3,384	1,647	2,038	1,249	1,542	1,262	1,196
Long-Term Debt	1,490	1,489	1,487	1,695	673	1,141	890	1,182	1,056	1,016
Other Noncurrent Operating Liabilities	893	1,307	1,393	1,689	974	897	359	360	206	181
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	2,373	5,745	6,599	10,740	4,694	4,613	3,845	2,749	2,270	1,849
Total Preferred & Common Equity	2,373	5,745	6,599	10,740	4,694	4,613	3,758	2,749	2,197	1,849
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	2,373	5,745	6,599	10,740	4,694	4,613	3,758	2,749	2,197	1,849
Common Stock	7,527	9,557	9,209	8,940	3,817	3,562	3,292	2,835	2,735	2,499
Retained Earnings	-1,242	-19	1,142	5,485	4,723	4,067	3,083	2,256	1,485	1,023
Treasury Stock	-3,934	-3,792	-3,755	-3,702	-3,848	-3,021	-2,616	-2,341	-2,022	-1,674
Accumulated Other Comprehensive Income / (Loss)	22	-1.00	3.00	17	2.00	5.00	-1.00	-1.00	-1.00	0.04

This table presents Illumina's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/30/2025	12/29/2024	9/29/2024	6/30/2024	3/31/2024	12/31/2023	10/1/2023	7/2/2023	4/2/2023	1/1/2023	10/2/2022
Total Assets	6,182	6,303	6,014	6,081	10,040	10,111	10,122	11,774	11,811	12,252	11,256
Total Current Assets	2,673	2,746	2,373	2,459	2,583	2,609	2,506	3,223	3,172	3,561	2,487
Cash & Equivalents	1,113	1,127	869	920	1,108	1,048	927	1,553	1,494	2,011	1,000
Short-Term Investments	124	93	70	74	-	6.00	6.00	6.00	24	26	41
Accounts Receivable	699	735	699	641	635	734	690	741	665	671	628
Inventories, net	537	547	574	561	584	587	615	617	586	568	559
Prepaid Expenses	200	244	161	263	256	234	268	306	403	285	259
Plant, Property, & Equipment, net	782	815	832	859	964	1,007	1,040	1,069	1,082	1,091	1,068
Total Noncurrent Assets	2,727	2,742	2,809	2,763	6,493	6,495	6,576	7,482	7,557	7,600	7,701
Goodwill	1,113	1,113	1,113	1,079	2,545	2,545	2,527	3,239	3,239	3,239	3,238
Intangible Assets	278	295	305	278	2,940	2,993	3,029	3,188	3,237	3,285	3,335
Noncurrent Deferred & Refundable Income Taxes	553	567	617	632	-	56	-	-	-	-	-
Other Noncurrent Operating Assets	783	767	774	774	1,008	901	1,020	1,055	1,081	1,076	1,128
Total Liabilities & Shareholders' Equity	6,182	6,303	6,014	6,081	10,040	10,111	10,122	11,774	11,811	12,252	11,256
Total Liabilities	3,814	3,930	3,889	4,645	4,306	4,366	4,224	5,219	5,118	5,653	4,525
Total Current Liabilities	1,440	1,547	975	2,208	1,474	1,570	1,482	2,303	2,230	2,773	2,669
Short-Term Debt	499	499	-	744	-	0.00	0.00	750	749	1,248	1,246
Accounts Payable	207	221	191	199	201	245	240	244	242	293	281
Accrued Expenses	734	827	784	1,265	1,273	1,325	1,242	1,309	1,239	1,232	1,142
Total Noncurrent Liabilities	2,374	2,383	2,914	2,437	2,832	2,796	2,742	2,916	2,888	2,880	1,856
Long-Term Debt	1,491	1,490	1,988	1,490	1,490	1,489	1,489	1,488	1,487	1,487	495
Other Noncurrent Operating Liabilities	883	893	926	947	1,342	1,307	1,253	1,428	1,401	1,393	1,361
Total Equity & Noncontrolling Interests	2,368	2,373	2,125	1,436	5,734	5,745	5,898	6,555	6,693	6,599	6,731
Total Preferred & Common Equity	2,368	2,373	2,125	1,436	5,734	5,745	5,898	6,555	6,693	6,599	6,731
Total Common Equity	2,368	2,373	2,125	1,436	5,734	5,745	5,898	6,555	6,693	6,599	6,731
Common Stock	7,610	7,527	7,451	7,349	9,660	9,557	9,489	9,399	9,313	9,209	9,131
Retained Earnings	-1,111	-1,242	-1,428	-2,133	-145	-19	157	911	1,145	1,142	1,281
Treasury Stock	-4,139	-3,934	-3,893	-	-3,793	-3,792	-3,769	-3,767	-3,764	-3,755	-3,720
Accumulated Other Comprehensive Income / (Loss)	8.00	22	-5.00	14	12	-1.00	21	12	-1.00	3.00	39

This table displays calculated financial ratios and metrics derived from Illumina's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/29/2024	12/31/2023	1/1/2023	1/2/2022	1/3/2021	12/29/2019	12/30/2018	12/31/2017	1/1/2017	1/3/2016
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-2.93%	-1.75%	1.28%	39.73%	-8.58%	6.30%	21.11%	14.76%	8.02%	19.27%
EBITDA Growth	-15.77%	83.04%	-419.79%	12.56%	-17.91%	17.92%	-9.62%	65.17%	-2.08%	21.84%
EBIT Growth	-2.46%	74.59%	-557.25%	9.38%	-21.10%	20.73%	-14.51%	81.68%	-3.47%	25.48%
NOPAT Growth	22.08%	74.42%	-2,659.07%	-123.85%	-49.04%	12.93%	96.07%	-12.04%	-7.00%	18.82%
Net Income Growth	-5.34%	73.64%	-677.95%	16.16%	-33.74%	26.60%	15.34%	58.41%	-6.55%	29.62%
EPS Growth	-4.77%	73.64%	-677.95%	13.26%	-33.98%	21.22%	13.01%	60.26%	-0.97%	30.80%
Operating Cash Flow Growth	75.10%	21.94%	-28.07%	-49.54%	2.76%	-7.97%	30.51%	12.32%	-0.89%	56.80%
Free Cash Flow Firm Growth	565.83%	-57.80%	109.93%	-2,424.00%	-59.00%	132.33%	108.13%	-13.33%	15.28%	-44.89%
Invested Capital Growth	-49.16%	-15.31%	-34.24%	361.18%	2.82%	-2.13%	18.60%	11.20%	14.35%	22.43%
Revenue Q/Q Growth	-0.41%	0.85%	-2.45%	5.75%	0.03%	-13.31%	27.46%	6.13%	1.15%	3.71%
EBITDA Q/Q Growth	29.59%	1.33%	-6.97%	-11.78%	3.90%	3.02%	0.45%	7.87%	-0.20%	-6.86%
EBIT Q/Q Growth	24.34%	0.54%	-6.59%	-17.32%	4.22%	4.68%	-1.52%	9.38%	-0.84%	-8.92%
NOPAT Q/Q Growth	28.80%	-3.49%	-4.21%	-300.08%	-19.42%	6.50%	19.20%	-0.50%	0.79%	-9.62%
Net Income Q/Q Growth	22.84%	-3.29%	-6.07%	-15.89%	2.82%	4.43%	21.62%	-6.74%	0.83%	-9.81%
EPS Q/Q Growth	22.87%	-3.29%	-6.07%	-15.44%	3.49%	2.90%	20.61%	-6.11%	2.68%	-9.62%
Operating Cash Flow Q/Q Growth	20.09%	19.20%	-25.62%	-18.54%	-3.31%	15.75%	0.53%	3.80%	-11.86%	40.42%
Free Cash Flow Firm Q/Q Growth	-0.25%	45.21%	12.45%	-3.57%	-6.91%	14.69%	5.14%	44.87%	-3.32%	7.80%
Invested Capital Q/Q Growth	-1.01%	-4.25%	-1.80%	0.74%	-5.61%	-2.66%	0.04%	-4.91%	-2.31%	-3.29%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	65.44%	60.92%	64.83%	69.69%	68.01%	69.63%	69.01%	66.35%	69.47%	69.77%
EBITDA Margin	-17.63%	-14.79%	-85.67%	27.13%	33.68%	37.51%	33.81%	45.31%	31.48%	34.73%
Operating Margin	-19.05%	-23.73%	-91.16%	-2.72%	17.91%	27.80%	26.49%	22.02%	24.48%	27.61%
EBIT Margin	-25.73%	-24.38%	-94.26%	20.88%	26.67%	30.91%	27.21%	38.55%	24.35%	27.25%
Profit (Net Income) Margin	-27.97%	-25.78%	-96.07%	16.84%	20.25%	27.94%	23.46%	24.64%	17.85%	20.63%
Tax Burden Percent	103.73%	103.94%	101.57%	86.20%	76.64%	88.55%	87.47%	65.00%	76.29%	78.56%
Interest Burden Percent	104.80%	101.73%	100.35%	93.55%	99.07%	102.10%	98.57%	98.30%	96.06%	96.36%
Effective Tax Rate	0.00%	0.00%	0.00%	13.80%	23.36%	11.45%	12.53%	35.00%	23.71%	21.44%
Return on Invested Capital (ROIC)	-12.51%	-11.10%	-31.81%	-1.57%	18.73%	36.87%	35.05%	20.58%	26.36%	33.44%
ROIC Less NNEP Spread (ROIC-NNEP)	-118.81%	-83.96%	-312.40%	-91.43%	9.46%	30.65%	34.27%	-18.50%	31.34%	30.68%
Return on Net Nonoperating Assets (RNNOA)	-17.62%	-7.71%	-18.99%	11.44%	-4.63%	-13.63%	-12.30%	5.09%	-5.95%	44.79%
Return on Equity (ROE)	-30.13%	-18.81%	-50.80%	9.87%	14.10%	23.24%	22.75%	25.67%	20.40%	78.23%
Cash Return on Invested Capital (CROIC)	52.67%	5.47%	9.50%	-130.29%	15.95%	39.03%	18.03%	9.97%	12.96%	13.27%
Operating Return on Assets (OROA)	-13.71%	-9.82%	-31.46%	8.29%	11.60%	15.34%	14.85%	22.25%	14.66%	17.22%
Return on Assets (ROA)	-14.90%	-10.38%	-32.07%	6.68%	8.80%	13.87%	12.80%	14.22%	10.74%	13.03%
Return on Common Equity (ROCE)	-30.13%	-18.81%	-50.80%	9.87%	14.10%	22.84%	21.53%	24.03%	19.68%	76.05%
Return on Equity Simple (ROE_SIMPLE)	-51.54%	-20.21%	-66.74%	7.10%	13.98%	21.46%	20.81%	24.66%	19.48%	24.78%
Net Operating Profit after Tax (NOPAT)	-583	-748	-2,925	-106	444	872	772	394	448	482
NOPAT Margin	-13.34%	-16.61%	-63.82%	-2.34%	13.72%	24.62%	23.17%	14.31%	18.68%	21.69%
Net Nonoperating Expense Percent (NNEP)	106.30%	72.85%	280.59%	89.86%	9.27%	6.22%	0.78%	39.07%	-4.98%	2.76%
Return On Investment Capital (ROIC_SIMPLE)	-13.37%	-10.34%	-31.34%	-	-	-	-	-	-	-
Cost of Revenue to Revenue	34.56%	39.08%	35.17%	30.31%	31.99%	30.37%	30.99%	33.65%	30.53%	30.23%
SG&A Expenses to Revenue	24.98%	35.79%	28.29%	46.22%	29.05%	23.57%	23.82%	24.49%	24.35%	23.24%
R&D to Revenue	26.74%	30.06%	28.82%	26.18%	21.06%	18.26%	18.69%	19.84%	21.02%	18.06%
Operating Expenses to Revenue	84.49%	84.66%	156.00%	72.40%	50.11%	41.83%	42.51%	44.33%	45.00%	42.16%
Earnings before Interest and Taxes (EBIT)	-1,125	-1,098	-4,321	945	864	1,095	907	1,061	584	605
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-771	-666	-3,927	1,228	1,091	1,329	1,127	1,247	755	771
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	9.04	3.85	4.82	5.54	11.51	10.59	11.67	11.60	8.56	15.20
Price to Tangible Book Value (P/TBV)	22.23	106.82	424.08	157.73	14.78	13.40	15.99	17.69	15.97	34.17
Price to Revenue (P/Rev)	4.91	4.91	6.94	13.14	16.68	13.79	13.15	11.59	7.84	12.66
Price to Earnings (P/E)	0.00	0.00	0.00	78.04	82.35	48.75	53.07	43.94	40.62	60.82
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	1.28%	1.21%	2.05%	1.88%	2.28%	2.46%	1.64%
Enterprise Value to Invested Capital (EV/IC)	7.07	3.65	4.45	5.39	21.50	19.90	17.76	15.46	10.16	17.56
Enterprise Value to Revenue (EV/Rev)	5.08	5.01	7.09	13.22	15.97	13.15	12.74	11.33	7.68	12.54
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	48.71	47.42	35.04	37.69	24.99	24.40	36.11
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	63.30	59.88	42.53	46.83	29.37	31.55	46.01
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	116.39	53.40	54.99	79.12	41.14	57.81
Enterprise Value to Operating Cash Flow (EV/OCF)	26.55	47.17	82.92	109.76	47.90	44.31	37.19	35.62	23.65	35.42
Enterprise Value to Free Cash Flow (EV/FCFF)	9.05	61.15	37.20	0.00	136.68	50.45	106.88	163.24	83.64	145.67
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.84	0.26	0.41	0.16	0.25	0.25	0.51	0.40	0.46	0.58
Long-Term Debt to Equity	0.63	0.26	0.23	0.16	0.14	0.25	0.23	0.40	0.46	0.54
Financial Leverage	0.15	0.09	0.06	-0.13	-0.49	-0.44	-0.36	-0.28	-0.19	1.46
Leverage Ratio	2.02	1.81	1.58	1.48	1.60	1.68	1.78	1.81	1.90	6.00
Compound Leverage Factor	2.12	1.84	1.59	1.38	1.59	1.71	1.75	1.77	1.82	5.78
Debt to Total Capital	45.60%	20.58%	29.30%	13.63%	20.14%	19.83%	33.83%	28.65%	31.38%	36.70%
Short-Term Debt to Total Capital	11.44%	0.00%	13.37%	0.00%	8.69%	0.00%	18.75%	0.24%	0.06%	2.52%
Long-Term Debt to Total Capital	34.16%	20.58%	15.93%	13.63%	11.45%	19.83%	15.08%	28.41%	31.32%	34.18%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	2.51%	5.29%	3.47%	1.10%
Common Equity to Total Capital	54.40%	79.42%	70.70%	86.37%	79.86%	80.17%	63.66%	66.07%	65.15%	62.21%
Debt to EBITDA	-2.58	-2.24	-0.70	1.38	1.09	0.86	1.77	0.96	1.40	1.41
Net Debt to EBITDA	-1.00	-0.65	-0.18	0.29	-2.10	-1.71	-1.34	-0.76	-0.66	-0.38
Long-Term Debt to EBITDA	-1.93	-2.24	-0.38	1.38	0.62	0.86	0.79	0.95	1.40	1.32
Debt to NOPAT	-3.41	-1.99	-0.93	-15.99	2.66	1.31	2.59	3.03	2.36	2.26
Net Debt to NOPAT	-1.32	-0.58	-0.24	-3.36	-5.15	-2.61	-1.96	-2.42	-1.12	-0.61
Long-Term Debt to NOPAT	-2.56	-1.99	-0.51	-15.99	1.51	1.31	1.15	3.00	2.36	2.11
Altman Z-Score	3.33	3.25	2.79	9.10	13.40	13.22	10.61	10.67	7.69	11.35
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	1.74%	5.35%	6.38%	3.56%	2.78%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.78	1.66	1.28	2.48	3.60	6.69	2.49	3.99	3.29	3.43
Quick Ratio	1.26	1.14	0.98	1.82	3.18	6.00	2.23	3.43	2.75	2.90
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	2,455	369	874	-8,796	378	923	397	191	220	191
Operating Cash Flow to CapEx	653.91%	245.13%	137.06%	262.02%	571.43%	502.87%	385.81%	282.26%	299.62%	549.65%
Free Cash Flow to Firm to Interest Expense	24.55	4.79	33.60	-144.20	7.72	17.75	6.97	5.16	6.68	4.44
Operating Cash Flow to Interest Expense	8.37	6.21	15.08	8.93	22.04	20.21	20.04	23.65	23.61	18.28
Operating Cash Flow Less CapEx to Interest Expense	7.09	3.68	4.08	5.52	18.18	16.19	14.84	15.27	15.73	14.95
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.53	0.40	0.33	0.40	0.43	0.50	0.55	0.58	0.60	0.63
Accounts Receivable Turnover	5.95	6.41	6.95	7.98	6.11	6.52	7.21	6.95	6.26	6.58
Inventory Turnover	2.66	3.05	3.23	3.42	2.83	2.89	2.87	2.93	2.56	2.91
Fixed Asset Turnover	4.80	4.29	4.33	4.65	3.58	3.61	3.32	3.35	4.54	7.30
Accounts Payable Turnover	6.49	6.54	5.16	5.24	6.08	6.46	6.01	6.21	5.28	6.05
Days Sales Outstanding (DSO)	61.32	56.93	52.51	45.77	59.73	55.99	50.65	52.52	58.34	55.49
Days Inventory Outstanding (DIO)	136.97	119.77	113.10	106.81	128.77	126.36	127.03	124.75	142.30	125.63
Days Payable Outstanding (DPO)	56.28	55.79	70.76	69.70	60.07	56.48	60.77	58.73	69.12	60.34
Cash Conversion Cycle (CCC)	142.00	120.91	94.85	82.88	128.43	125.87	116.90	118.55	131.52	120.78
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	3,142	6,180	7,297	11,096	2,406	2,340	2,391	2,016	1,813	1,585
Invested Capital Turnover	0.94	0.67	0.50	0.67	1.36	1.50	1.51	1.44	1.41	1.54
Increase / (Decrease) in Invested Capital	-3,038	-1,117	-3,799	8,690	66	-51	375	203	228	290
Enterprise Value (EV)	22,223	22,546	32,504	59,819	51,732	46,574	42,473	31,167	18,425	27,838
Market Capitalization	21,454	22,111	31,806	59,463	54,020	48,847	43,840	31,900	18,809	28,101
Book Value per Share	$14.96	$36.18	$41.95	$68.71	$32.15	$31.38	$25.56	$18.83	$14.96	$12.63
Tangible Book Value per Share	$6.08	$1.30	$0.48	$2.41	$25.03	$24.79	$18.65	$12.35	$8.02	$5.62
Total Capital	4,362	7,234	9,334	12,435	5,878	5,754	5,903	4,161	3,372	2,972
Total Debt	1,989	1,489	2,735	1,695	1,184	1,141	1,997	1,192	1,058	1,091
Total Long-Term Debt	1,490	1,489	1,487	1,695	673	1,141	890	1,182	1,056	1,016
Net Debt	769	435	698	356	-2,288	-2,273	-1,515	-953	-501	-296
Capital Expenditures (CapEx)	128	195	286	208	189	209	296	310	260	143
Debt-free, Cash-free Net Working Capital (DFCFNWC)	478	-15	-1.00	281	278	372	281	99	56	175
Debt-free Net Working Capital (DFNWC)	1,698	1,039	2,036	1,620	3,750	3,786	3,793	2,244	1,615	1,561
Net Working Capital (NWC)	1,199	1,039	788	1,620	3,239	3,786	2,686	2,234	1,613	1,486
Net Nonoperating Expense (NNE)	640	413	1,479	-868	-212	-118	-9.62	-284	20	24
Net Nonoperating Obligations (NNO)	769	435	698	356	-2,288	-2,273	-1,515	-953	-501	-296
Total Depreciation and Amortization (D&A)	354	432	394	283	227	234	220	186	171	166
Debt-free, Cash-free Net Working Capital to Revenue	10.93%	-0.33%	-0.02%	6.21%	8.58%	10.50%	8.43%	3.60%	2.34%	7.88%
Debt-free Net Working Capital to Revenue	38.84%	23.07%	44.42%	35.79%	115.78%	106.86%	113.80%	81.54%	67.35%	70.33%
Net Working Capital to Revenue	27.42%	23.07%	17.19%	35.79%	100.00%	106.86%	80.59%	81.18%	67.26%	66.95%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($7.69)	($7.13)	($27.21)	$4.93	$4.35	$6.62	$5.47	$4.82	$3.00	$3.10
Adjusted Weighted Average Basic Shares Outstanding	159M	162.58M	161.55M	154.35M	151.26M	151.26M	151.26M	150.23M	151.04M	149.02M
Adjusted Diluted Earnings per Share	($7.69)	($7.13)	($27.21)	$4.90	$4.32	$6.55	$5.40	$4.78	$2.98	$3.01
Adjusted Weighted Average Diluted Shares Outstanding	159M	162.58M	161.55M	155.38M	152.29M	153.32M	153.32M	152.29M	152.33M	153.39M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$6.62	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	158.40M	163.51M	162.58M	161.55M	150.13M	151.26M	151.26M	151.26M	150.54M	151.26M
Normalized Net Operating Profit after Tax (NOPAT)	420	-155	248	-106	444	872	772	394	441	496
Normalized NOPAT Margin	9.61%	-3.45%	5.41%	-2.34%	13.72%	24.62%	23.17%	14.31%	18.39%	22.36%
Pre Tax Income Margin	-26.97%	-24.80%	-94.59%	19.53%	26.43%	31.56%	26.82%	37.90%	23.39%	26.26%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-11.25	-14.26	-166.19	15.49	17.63	21.06	15.91	28.68	17.70	14.07
NOPAT to Interest Expense	-5.83	-9.72	-112.51	-1.74	9.07	16.77	13.55	10.65	13.57	11.20
EBIT Less CapEx to Interest Expense	-12.53	-16.79	-177.19	12.08	13.78	17.04	10.72	20.30	9.82	10.74
NOPAT Less CapEx to Interest Expense	-7.11	-12.25	-123.51	-5.15	5.21	12.75	8.36	2.27	5.69	7.87
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-0.08%	-0.09%	0.00%	0.00%	0.00%	0.00%	0.00%	0.44%	6.78%	0.66%
Augmented Payout Ratio	-9.57%	-0.09%	0.00%	0.00%	112.20%	32.73%	25.70%	37.46%	64.95%	60.48%

This table displays calculated financial ratios and metrics derived from Illumina's official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/30/2025	12/29/2024	9/29/2024	6/30/2024	3/31/2024	12/31/2023	10/1/2023	7/2/2023	4/2/2023	1/1/2023	10/2/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-3.25%	-1.60%	-3.49%	-5.44%	-1.01%	3.51%	0.36%	1.20%	-11.12%	-9.59%	0.63%
EBITDA Growth	5,200.00%	635.29%	222.01%	-8,976.19%	-84.38%	15.00%	81.27%	103.90%	-86.50%	-130.61%	-804.74%
EBIT Growth	290.29%	226.25%	196.01%	-2,163.22%	-37.33%	3.61%	78.85%	86.23%	-151.37%	-264.36%	-945.39%
NOPAT Growth	251.92%	252.50%	237.47%	-1,760.23%	-73.44%	-28.35%	79.38%	84.80%	-139.64%	-264.84%	-522.32%
Net Income Growth	203.97%	205.68%	193.50%	-749.57%	-4,300.00%	-26.62%	80.24%	56.26%	-96.51%	-223.01%	-1,303.79%
EPS Growth	203.80%	205.41%	192.66%	-743.24%	-4,050.00%	-26.62%	80.24%	56.26%	-96.36%	-223.01%	-1,266.35%
Operating Cash Flow Growth	211.69%	62.50%	127.34%	-23.81%	670.00%	52.38%	367.31%	-16.00%	-94.19%	-47.87%	80.88%
Free Cash Flow Firm Growth	155.73%	220.27%	791.71%	-4.19%	-67.65%	-72.97%	-56.14%	140.99%	143.49%	142.96%	111.54%
Invested Capital Growth	-48.97%	-49.16%	-50.82%	-63.01%	-17.47%	-15.31%	-13.15%	-33.37%	-33.94%	-34.24%	-32.54%
Revenue Q/Q Growth	-5.71%	2.22%	-2.88%	3.35%	-4.10%	0.27%	-4.85%	8.19%	0.28%	-2.78%	-4.04%
EBITDA Q/Q Growth	-2.93%	-66.50%	143.72%	-37,380.00%	109.80%	92.37%	-3,280.95%	-34.38%	153.33%	98.32%	-562.83%
EBIT Q/Q Growth	-2.97%	-72.89%	137.84%	-1,811.65%	35.63%	79.38%	-791.95%	-16.00%	54.82%	95.48%	-480.54%
NOPAT Q/Q Growth	-32.16%	-76.02%	163.32%	-1,374.77%	31.90%	78.38%	-756.82%	-37.50%	49.61%	96.53%	-531.61%
Net Income Q/Q Growth	-29.57%	-73.62%	135.46%	-1,477.78%	28.41%	76.66%	-222.22%	-7,900.00%	102.16%	96.36%	-613.27%
EPS Q/Q Growth	-29.91%	-73.53%	135.42%	-1,479.75%	28.83%	76.66%	-222.22%	-7,900.00%	102.25%	96.36%	-613.53%
Operating Cash Flow Q/Q Growth	-34.07%	15.19%	295.00%	3.90%	-65.63%	61.15%	32.38%	950.00%	-93.20%	382.69%	-141.60%
Free Cash Flow Firm Q/Q Growth	-3.08%	-19.81%	17.39%	180.30%	21.38%	123.26%	-87.39%	-5.36%	1.43%	262.28%	111.79%
Invested Capital Q/Q Growth	-0.67%	-1.01%	18.61%	-56.25%	-1.04%	-4.25%	-10.78%	-2.39%	1.56%	-1.80%	-31.56%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	65.61%	65.94%	68.98%	64.84%	61.99%	59.98%	61.13%	62.24%	60.26%	62.08%	64.30%
EBITDA Margin	25.46%	24.73%	75.46%	-167.63%	0.46%	-4.55%	-59.70%	1.79%	2.94%	-5.54%	-319.82%
Operating Margin	15.75%	15.76%	68.61%	-147.21%	-10.32%	-14.53%	-67.38%	-7.48%	-5.89%	-11.72%	-327.98%
EBIT Margin	18.83%	18.30%	68.98%	-177.07%	-9.57%	-14.26%	-69.35%	-7.40%	-6.90%	-15.31%	-329.06%
Profit (Net Income) Margin	12.58%	16.85%	65.28%	-178.78%	-11.71%	-15.69%	-67.38%	-19.90%	0.28%	-12.82%	-342.24%
Tax Burden Percent	71.98%	100.00%	97.92%	100.61%	115.60%	104.76%	96.42%	262.92%	-3.85%	83.23%	103.92%
Interest Burden Percent	92.86%	92.08%	96.64%	100.36%	105.83%	105.00%	100.77%	102.30%	104.00%	100.60%	100.08%
Effective Tax Rate	28.02%	0.00%	2.08%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	10.65%	14.78%	61.26%	-92.11%	-4.80%	-6.80%	-30.34%	-2.58%	-1.97%	-4.09%	-116.97%
ROIC Less NNEP Spread (ROIC-NNEP)	12.93%	16.78%	58.70%	-179.87%	-13.58%	-17.72%	-66.36%	-34.16%	7.21%	-13.59%	-340.88%
Return on Net Nonoperating Assets (RNNOA)	1.81%	2.49%	11.74%	-43.20%	-1.20%	-1.63%	-6.60%	-2.19%	0.43%	-0.83%	-22.08%
Return on Equity (ROE)	12.46%	17.27%	73.01%	-135.31%	-6.00%	-8.42%	-36.94%	-4.78%	-1.54%	-4.91%	-139.05%
Cash Return on Invested Capital (CROIC)	56.39%	52.67%	51.12%	54.34%	7.60%	5.47%	3.66%	9.59%	7.61%	9.50%	8.42%
Operating Return on Assets (OROA)	10.07%	9.75%	37.53%	-87.84%	-3.94%	-5.74%	-28.97%	-2.43%	-2.27%	-5.11%	-117.50%
Return on Assets (ROA)	6.73%	8.98%	35.52%	-88.69%	-4.82%	-6.32%	-28.15%	-6.52%	0.09%	-4.28%	-122.21%
Return on Common Equity (ROCE)	12.46%	17.27%	73.01%	-135.31%	-6.00%	-8.42%	-36.94%	-4.78%	-1.54%	-4.91%	-139.05%
Return on Equity Simple (ROE_SIMPLE)	-40.79%	0.00%	-74.59%	-211.98%	-22.50%	0.00%	-19.06%	-63.86%	-67.04%	0.00%	-61.68%
Net Operating Profit after Tax (NOPAT)	118	174	726	-1,146	-78	-114	-528	-62	-45	-89	-2,560
NOPAT Margin	11.34%	15.76%	67.18%	-103.05%	-7.22%	-10.17%	-47.17%	-5.24%	-4.12%	-8.20%	-229.59%
Net Nonoperating Expense Percent (NNEP)	-2.28%	-1.99%	2.56%	87.76%	8.78%	10.93%	36.02%	31.58%	-9.17%	9.51%	223.90%
Return On Investment Capital (ROIC_SIMPLE)	2.71%	3.99%	-	-	-	-1.58%	-	-	-	-0.95%	-
Cost of Revenue to Revenue	34.39%	34.06%	31.02%	35.16%	38.01%	40.02%	38.87%	37.76%	39.74%	37.92%	35.70%
SG&A Expenses to Revenue	25.65%	24.18%	22.13%	13.22%	40.80%	41.80%	27.08%	39.29%	34.77%	39.94%	13.09%
R&D to Revenue	24.21%	22.83%	23.43%	29.23%	31.51%	30.30%	28.15%	30.44%	31.37%	31.92%	29.15%
Operating Expenses to Revenue	49.86%	50.18%	0.37%	212.05%	72.30%	74.51%	128.51%	69.73%	66.15%	73.80%	392.29%
Earnings before Interest and Taxes (EBIT)	196	202	745	-1,969	-103	-160	-776	-87	-75	-166	-3,669
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	265	273	815	-1,864	5.00	-51	-668	21	32	-60	-3,566
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	5.35	9.04	9.75	11.91	3.80	3.85	3.68	4.52	5.49	4.82	4.46
Price to Tangible Book Value (P/TBV)	12.97	22.23	29.32	216.58	87.58	106.82	63.54	231.58	169.32	424.08	189.94
Price to Revenue (P/Rev)	2.92	4.91	4.72	3.86	4.85	4.91	4.87	6.64	8.26	6.94	6.39
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	4.30	7.07	6.86	6.86	3.63	3.65	3.45	4.19	5.05	4.45	4.13
Enterprise Value to Revenue (EV/Rev)	3.10	5.08	4.96	4.14	4.94	5.01	4.99	6.80	8.42	7.09	6.54
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	13.43	26.55	31.24	35.29	40.71	47.17	55.58	144.39	162.87	82.92	58.28
Enterprise Value to Free Cash Flow (EV/FCFF)	5.15	9.05	8.85	6.82	43.18	61.15	87.78	34.94	52.83	37.20	39.53
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.84	0.84	0.94	1.56	0.26	0.26	0.25	0.34	0.33	0.41	0.26
Long-Term Debt to Equity	0.63	0.63	0.94	1.04	0.26	0.26	0.25	0.23	0.22	0.23	0.07
Financial Leverage	0.14	0.15	0.20	0.24	0.09	0.09	0.10	0.06	0.06	0.06	0.06
Leverage Ratio	2.00	2.02	2.01	2.23	1.76	1.81	1.69	1.60	1.54	1.58	1.52
Compound Leverage Factor	1.86	1.86	1.94	2.24	1.86	1.90	1.71	1.64	1.60	1.59	1.52
Debt to Total Capital	45.66%	45.60%	48.33%	60.87%	20.63%	20.58%	20.16%	25.45%	25.04%	29.30%	20.55%
Short-Term Debt to Total Capital	11.45%	11.44%	0.00%	20.27%	0.00%	0.00%	0.00%	8.53%	8.39%	13.37%	14.71%
Long-Term Debt to Total Capital	34.21%	34.16%	48.33%	40.60%	20.63%	20.58%	20.16%	16.92%	16.65%	15.93%	5.84%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	54.34%	54.40%	51.67%	39.13%	79.37%	79.42%	79.84%	74.55%	74.96%	70.70%	79.45%
Debt to EBITDA	-3.89	-2.58	-1.82	-0.87	-2.15	-2.24	-2.21	-0.63	-0.54	-0.70	-0.47
Net Debt to EBITDA	-1.47	-1.00	-0.96	-0.48	-0.55	-0.65	-0.82	-0.19	-0.17	-0.18	-0.19
Long-Term Debt to EBITDA	-2.92	-1.93	-1.82	-0.58	-2.15	-2.24	-2.21	-0.42	-0.36	-0.38	-0.13
Debt to NOPAT	-5.09	-3.41	-2.43	-1.20	-1.91	-1.99	-2.06	-0.81	-0.72	-0.93	-0.62
Net Debt to NOPAT	-1.93	-1.32	-1.28	-0.66	-0.49	-0.58	-0.77	-0.25	-0.23	-0.24	-0.25
Long-Term Debt to NOPAT	-3.82	-2.56	-2.43	-0.80	-1.91	-1.99	-2.06	-0.54	-0.48	-0.51	-0.18
Altman Z-Score	2.79	4.03	4.28	1.43	3.56	3.55	3.42	3.96	4.89	3.91	3.46
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.86	1.78	2.43	1.11	1.75	1.66	1.69	1.40	1.42	1.28	0.93
Quick Ratio	1.34	1.26	1.68	0.74	1.18	1.14	1.10	1.00	0.98	0.98	0.63
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	3,113	3,212	4,006	3,412	1,217	1,003	449	3,561	3,763	3,710	1,024
Operating Cash Flow to CapEx	750.00%	1,255.17%	987.50%	258.06%	213.89%	439.22%	308.89%	223.40%	19.23%	167.05%	-78.79%
Free Cash Flow to Firm to Interest Expense	124.52	123.54	111.27	170.61	67.63	52.78	23.64	187.44	188.16	463.76	170.68
Operating Cash Flow to Interest Expense	9.60	14.00	8.78	4.00	4.28	11.79	7.32	5.53	0.50	18.38	-8.67
Operating Cash Flow Less CapEx to Interest Expense	8.32	12.88	7.89	2.45	2.28	9.11	4.95	3.05	-2.10	7.38	-19.67
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.53	0.53	0.54	0.50	0.41	0.40	0.42	0.33	0.33	0.33	0.36
Accounts Receivable Turnover	6.50	5.95	6.32	6.41	6.91	6.41	6.78	6.45	6.96	6.95	7.63
Inventory Turnover	2.60	2.66	2.66	2.86	2.97	3.05	2.93	2.97	3.11	3.23	3.30
Fixed Asset Turnover	4.97	4.80	4.69	4.59	4.39	4.29	4.24	4.20	4.20	4.33	4.52
Accounts Payable Turnover	7.16	6.49	7.35	7.60	7.84	6.54	6.61	6.41	6.14	5.16	5.98
Days Sales Outstanding (DSO)	56.13	61.32	57.74	56.95	52.80	56.93	53.86	56.57	52.48	52.51	47.85
Days Inventory Outstanding (DIO)	140.13	136.97	136.99	127.66	122.93	119.77	124.42	122.93	117.24	113.10	110.75
Days Payable Outstanding (DPO)	51.00	56.28	49.66	48.01	46.54	55.79	55.22	56.97	59.46	70.76	61.03
Cash Conversion Cycle (CCC)	145.26	142.00	145.08	136.60	129.19	120.91	123.07	122.53	110.26	94.85	97.57
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	3,121	3,142	3,174	2,676	6,116	6,180	6,454	7,234	7,411	7,297	7,431
Invested Capital Turnover	0.94	0.94	0.91	0.89	0.66	0.67	0.64	0.49	0.48	0.50	0.51
Increase / (Decrease) in Invested Capital	-2,995	-3,038	-3,280	-4,558	-1,295	-1,117	-977	-3,623	-3,808	-3,799	-3,584
Enterprise Value (EV)	13,425	22,223	21,777	18,350	22,188	22,546	22,287	30,321	37,461	32,504	30,711
Market Capitalization	12,672	21,454	20,728	17,110	21,806	22,111	21,731	29,642	36,743	31,806	30,011
Book Value per Share	$14.95	$14.96	$13.34	$9.01	$36.06	$36.18	$37.26	$41.46	$42.36	$41.95	$42.79
Tangible Book Value per Share	$6.17	$6.08	$4.44	$0.50	$1.57	$1.30	$2.16	$0.81	$1.37	$0.48	$1.00
Total Capital	4,358	4,362	4,113	3,670	7,224	7,234	7,387	8,793	8,929	9,334	8,472
Total Debt	1,990	1,989	1,988	2,234	1,490	1,489	1,489	2,238	2,236	2,735	1,741
Total Long-Term Debt	1,491	1,490	1,988	1,490	1,490	1,489	1,489	1,488	1,487	1,487	495
Net Debt	753	769	1,049	1,240	382	435	556	679	718	698	700
Capital Expenditures (CapEx)	32	29	32	31	36	51	45	47	52	88	66
Debt-free, Cash-free Net Working Capital (DFCFNWC)	495	478	459	1.00	1.00	-15	91	111	173	-1.00	23
Debt-free Net Working Capital (DFNWC)	1,732	1,698	1,398	995	1,109	1,039	1,024	1,670	1,691	2,036	1,064
Net Working Capital (NWC)	1,233	1,199	1,398	251	1,109	1,039	1,024	920	942	788	-182
Net Nonoperating Expense (NNE)	-13	-12	21	842	48	62	226	172	-48	50	1,256
Net Nonoperating Obligations (NNO)	753	769	1,049	1,240	382	435	556	679	718	698	700
Total Depreciation and Amortization (D&A)	69	71	70	105	108	109	108	108	107	106	103
Debt-free, Cash-free Net Working Capital to Revenue	11.41%	10.93%	10.46%	0.02%	0.02%	-0.33%	2.04%	2.49%	3.89%	-0.02%	0.49%
Debt-free Net Working Capital to Revenue	39.94%	38.84%	31.85%	22.47%	24.68%	23.07%	22.93%	37.43%	38.02%	44.42%	22.64%
Net Working Capital to Revenue	28.43%	27.42%	31.85%	5.67%	24.68%	23.07%	22.93%	20.62%	21.18%	17.19%	-3.87%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.83	$1.17	$4.43	($12.48)	($0.77)	($1.08)	($4.64)	($1.44)	$0.02	($0.86)	($23.58)
Adjusted Weighted Average Basic Shares Outstanding	159M	159M	159M	159M	163.61M	162.58M	162.58M	162.58M	162.58M	161.55M	161.55M
Adjusted Diluted Earnings per Share	$0.82	$1.17	$4.42	($12.48)	($0.77)	($1.08)	($4.64)	($1.44)	$0.02	($0.86)	($23.58)
Adjusted Weighted Average Diluted Shares Outstanding	159M	159M	160M	159M	163.61M	162.58M	162.58M	162.58M	162.58M	161.55M	161.55M
Adjusted Basic & Diluted Earnings per Share	$0.00	$1.17	$0.00	$0.00	$0.00	($1.08)	$0.00	$0.00	$0.00	($0.86)	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	158.30M	158.40M	158.60M	159.30M	163.92M	163.51M	163.40M	162.89M	162.68M	162.58M	161.86M
Normalized Net Operating Profit after Tax (NOPAT)	118	122	248	174	-78	-114	46	-62	-45	-89	172
Normalized NOPAT Margin	11.34%	11.03%	22.94%	15.67%	-7.22%	-10.17%	4.13%	-5.24%	-4.12%	-8.20%	15.44%
Pre Tax Income Margin	17.48%	16.85%	66.67%	-177.70%	-10.13%	-14.97%	-69.88%	-7.57%	-7.18%	-15.41%	-329.33%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	7.84	7.77	20.69	-98.45	-5.72	-8.42	-40.84	-4.58	-3.75	-20.75	-611.50
NOPAT to Interest Expense	4.72	6.69	20.15	-57.30	-4.32	-6.01	-27.78	-3.24	-2.24	-11.11	-426.65
EBIT Less CapEx to Interest Expense	6.56	6.65	19.81	-100.00	-7.72	-11.11	-43.21	-7.05	-6.35	-31.75	-622.50
NOPAT Less CapEx to Interest Expense	3.44	5.58	19.27	-58.85	-6.32	-8.69	-30.15	-5.72	-4.84	-22.11	-437.65
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	-0.08%	0.00%	0.00%	0.00%	-0.09%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	-32.71%	-9.57%	0.00%	0.00%	0.00%	-0.09%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions About Illumina's Financials

When does Illumina's fiscal year end?

According to the most recent income statement we have on file, Illumina's financial year ends in December. Their financial year 2024 ended on December 29, 2024.

How has Illumina's net income changed over the last 9 years?

Illumina's net income appears to be on an upward trend, with a most recent value of -$1.22 billion in 2024, falling from $458 million in 2015. The previous period was -$1.16 billion in 2023. See Illumina's forecast for analyst expectations on what’s next for the company.

What is Illumina's operating income?

Illumina's total operating income in 2024 was -$833 million, based on the following breakdown:

Total Gross Profit: $2.86 billion
Total Operating Expenses: $3.69 billion

How has Illumina revenue changed over the last 9 years?

Over the last 9 years, Illumina's total revenue changed from $2.22 billion in 2015 to $4.37 billion in 2024, a change of 96.9%.

How much debt does Illumina have?

Illumina's total liabilities were at $3.93 billion at the end of 2024, a 10.0% decrease from 2023, and a 117.5% increase since 2015.

How much cash does Illumina have?

In the past 9 years, Illumina's cash and equivalents has ranged from $735 million in 2016 to $2.04 billion in 2019, and is currently $1.13 billion as of their latest financial filing in 2024.

How has Illumina's book value per share changed over the last 9 years?

Over the last 9 years, Illumina's book value per share changed from 12.63 in 2015 to 14.96 in 2024, a change of 18.5%.

Related Companies

This page (NASDAQ:ILMN) was last updated on 5/28/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Illumina (ILMN) Financials

Frequently Asked Questions About Illumina's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Illumina (ILMN) Financials

Annual Income Statements for Illumina

Quarterly Income Statements for Illumina

Annual Cash Flow Statements for Illumina

Quarterly Cash Flow Statements for Illumina

Annual Balance Sheets for Illumina

Quarterly Balance Sheets for Illumina

Annual Metrics And Ratios for Illumina

Quarterly Metrics And Ratios for Illumina

Frequently Asked Questions About Illumina's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools